Enhancing the Functionality of Mesenchymal Stem Cells: An Attractive Treatment Strategy for Metabolic Dysfunction-Associated Steatotic Liver Disease?

The intrinsic heterogeneity of metabolic dysfunction-associated fatty liver disease (MASLD) and the intricate pathogenesis have impeded the advancement and clinical implementation of therapeutic interventions, underscoring the critical dema 

Read More